oxymetholone 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| steroids not used as glucocorticosteroids | 2033 | 434-07-1 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002), this compound may reasonably be anticipated to be a carcinogen. (From Merck Index, 11th ed)
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 0.25 | g | O |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 15.04 µM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 2 | Bocci G, Oprea TI, Benet LZ |
| S (Water solubility) | 0.01 mg/mL | Bocci G, Oprea TI, Benet LZ |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Jan. 18, 1972 | FDA | MEDA PHARMS |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | A14AA05 | ALIMENTARY TRACT AND METABOLISM ANABOLIC AGENTS FOR SYSTEMIC USE ANABOLIC STEROIDS Androstan derivatives |
| MeSH PA | D045930 | Anabolic Agents |
| MeSH PA | D000728 | Androgens |
| MeSH PA | D006728 | Hormones |
| CHEBI has role | CHEBI:50113 | androgene |
| CHEBI has role | CHEBI:75835 | antianaemic drug |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Hypoplastic anemia | indication | 41614006 | |
| Congenital hypoplastic anemia | indication | 88854002 | DOID:1339 |
| Aplastic anemia | indication | 306058006 | DOID:12449 |
| Hypercholesterolemia | contraindication | 13644009 | |
| Humoral hypercalcemia of malignancy | contraindication | 47709007 | |
| Chronic heart failure | contraindication | 48447003 | |
| Nephrotic syndrome | contraindication | 52254009 | DOID:1184 |
| Heart disease | contraindication | 56265001 | DOID:114 |
| Peliosis hepatis | contraindication | 58008004 | DOID:914 |
| Hepatic failure | contraindication | 59927004 | |
| Blood coagulation disorder | contraindication | 64779008 | DOID:1247 |
| Arteriosclerotic vascular disease | contraindication | 72092001 | |
| Diabetes mellitus | contraindication | 73211009 | DOID:9351 |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Neoplasm of prostate | contraindication | 126906006 | DOID:10283 |
| Liver function tests abnormal | contraindication | 166603001 | |
| Hypoalphalipoproteinemia | contraindication | 190785000 | |
| Disease of liver | contraindication | 235856003 | DOID:409 |
| Benign prostatic hyperplasia | contraindication | 266569009 | |
| Edema | contraindication | 267038008 | |
| Pregnancy, function | contraindication | 289908002 | |
| Breastfeeding (mother) | contraindication | 413712001 | |
| Disorder of coronary artery | contraindication | 414024009 | |
| Carcinoma of female breast | contraindication | 447782002 | |
| Breast Carcinoma in Males | contraindication |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 8.87 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Androgen receptor | Nuclear hormone receptor | AGONIST | WOMBAT-PK | CHEMBL | |||||
| Estrogen receptor | Nuclear hormone receptor | WOMBAT-PK | |||||||
| Androgen receptor | Transcription factor | Ki | 6.86 | DRUG MATRIX |
External reference:
| ID | Source |
|---|---|
| 4018432 | VUID |
| N0000146758 | NUI |
| D00490 | KEGG_DRUG |
| 4018432 | VANDF |
| C0030072 | UMLSCUI |
| CHEBI:7864 | CHEBI |
| CHEMBL1200585 | ChEMBL_ID |
| DB06412 | DRUGBANK_ID |
| D010110 | MESH_DESCRIPTOR_UI |
| 5281034 | PUBCHEM_CID |
| 1022 | INN_ID |
| L76T0ZCA8K | UNII |
| 7813 | RXNORM |
| 5219 | MMSL |
| d04295 | MMSL |
| 001255 | NDDF |
| 126101002 | SNOMEDCT_US |
| 6116004 | SNOMEDCT_US |
Pharmaceutical products:
None